337. Homocystinuria Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 23 / Drugs : 31 - (DrugBank : 11) / Drug target genes : 3 - Drug target pathways : 26
| Other names | - | ||
|---|---|---|---|
| Disease group | Metabolic diseases | ||
|
Domestic patients
Med expenses recipients, FY2024 (corrected) (in Japanese) |
33 patients Age distribution
 💬 |
||
| Clinical research form (in Japanese) MHLW Intractable Diseases, FY2026 (in Japanese) | Overview, diagnostic criteria, etc. (pdf), Clinical research form (pdf) 337-01, 337-02, 337-03 | ||
| Specific pediatric chronic diseases, Japan (in Japanese) | 8-1-8. Homocystinuria | ||
| Sub-diseases (Clinical research forms may not be available for all sub-diseases.) | No. | Name | Specific pediatric chronic diseases, Japan (in Japanese) |
| 337-1. | Homocystinuria type I;Cystathionine beta-synthase deficiency;CBS deficiency; | 8-1-8. Homocystinuria | |
| 337-2. | Homocystinuria type II;Homocystinuria cblC type;Cobalamin C deficiency;cblC deficiency; | 8-1-8. Homocystinuria | |
| 337-3. | Homocystinuria type III;Methylenetetrahydrofolate reductase deficiency;MTHFR deficiency; | 8-1-8. Homocystinuria | |